Benfosformin

This classification denotes an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 49030P3C8S. European Medicines Agency schedules Benfosformin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05715MIG. Benfosformin generally arises in the molecular formula C9H12N5O3P.2NA.H2O. The term BENFOSFORMIN is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 27, no. 10 1973, list 13.) BENFOSFORMIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule benfosformin under HS 29299000 and SITC 51489. As of Q4 2014, BENFOSFORMIN remains US FDA's Preferred Term for this commodity. Benfosformin bears US NLM identifiers UMLS ID C2346994 and NCI Concept Code C72721. SMILES: P(=O)(O)(O)/N=C(/N/C(=N/CC1CCCCC1)N)N.[NA].[NA].O.